Stuart Ingis on the benefits of showing the public how advertisers and marketers use data and creating a global regulatory framework.
Insys founder John Kapoor has maintained his innocence in the face of charges.
MM&M is honoring 15 of the most-senior women in healthcare along with 20 Women to Watch who are changing the industry.
AstraZeneca lung cancer drug meets key goal; Johnson & Johnson loses another talc lawsuit; Cancer drugs account for 80% of drug sales.
As of May 25, Europe's groundbreaking General Data Protection Regulation (GDPR) will take effect, fundamentally changing the way businesses and government agencies deal with personal data.
Publicis Groupe unveiled its much-anticipated AI-powered platform Marcel at its VivaTech event this morning in Paris.
Recro non-opioid injection receives complete response letter from FDA; Pfizer settles False Claims Act allegations; Medtronic reports better-than-expected profit.
Speakers at the Coalition for Healthcare Communication conference discussed how regulations from the White House and FDA have affected healthcare comms.
Accenture has taken another big step into the agency space by launching a programmatic media planning and buying unit.
Keytruda passes late-stage trial; Astellas to cut 600 jobs in restructuring; Teva expects FDA decision on migraine drug by mid-September.
Nanobiosym hired the agency shortly after its proprietary technology was approved by the FDA.
Geisinger looks to expand DNA sequencing program; Celgene invests $65 million more in Evotec; Oscar launches transparency push.
Plan D: Experts predict government savings, but higher co-pays with Trump plan for lowering drug prices
The White House's strategy calls for moving expensive treatments from under Medicare Part B to Medicare Part D.